Cinctive Capital Management LP bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 51,679 shares of the company’s stock, valued at approximately $4,959,000. Cinctive Capital Management LP owned about 0.06% of HealthEquity at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in HQY. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the fourth quarter worth $26,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of HealthEquity during the 4th quarter valued at about $39,000. UMB Bank n.a. increased its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its stake in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity Trading Up 1.9 %
NASDAQ:HQY opened at $88.74 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The stock has a market cap of $7.68 billion, a P/E ratio of 81.41, a P/E/G ratio of 1.60 and a beta of 0.62. The stock has a 50-day simple moving average of $102.66 and a 200-day simple moving average of $96.30.
Insider Activity at HealthEquity
Analysts Set New Price Targets
Several analysts have recently weighed in on HQY shares. KeyCorp dropped their price target on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. The Goldman Sachs Group lowered their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday, March 27th. Finally, Wells Fargo & Company raised their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $112.58.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Which Wall Street Analysts are the Most Accurate?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What is the Dogs of the Dow Strategy? Overview and Examples
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.